Annals of the American Thoracic Society
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Moral Distress and Other Wellness Measures in Canadian Critical Care Physicians
2021
-
The Efficacy and Safety of In–Intensive Care Unit Leg-Cycle Ergometry in Critically Ill Adults. A Systematic Review and Meta-analysis
2020
-
Effects of Controlled Diesel Exhaust and Allergen Exposure on microRNA and Gene Expression in Humans Modulation of Lung Inflammatory Markers Associated with Asthma
2018
-
Effects of Controlled Diesel Exhaust and Allergen Exposure on microRNA and Gene Expression in Humans. Modulation of Lung Inflammatory Markers Associated with Asthma
2018
-
An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases
2017
-
Purpose of the Conference: 2015 Transatlantic Airway Conference
2015
-
Integrating Patients into Meaningful Real-World Research
2014
-
A Guide to Guidelines for Professional Societies and Other Developers of Recommendations
2012
-
How to Integrate Multiple Comorbidities in Guideline Development
2012
-
Reporting and Publishing Guidelines
2012
-
Healthcare Utilization and Costs in Children Receiving Home Mechanical Ventilation in Ontario: A 14-Year Cohort Study.
21:1421-1431.
2024
-
The Diversity of Research Participants in Randomized Controlled Trials and Observational Studies Conducted by the Canadian Critical Care Trials Group.
21:1309-1315.
2024
-
Comparative Effectiveness of Sotatercept and Approved Add-On Pulmonary Arterial Hypertension Therapies: A Systematic Review and Network Meta-Analysis..
21:1194-1203.
2024
-
Organic Exposures, Radiologic Features, and Patterns in Fibrotic Interstitial Lung Disease.
21:1216-1218.
2024
-
Validation of a Dyspnea Visual Analog Scale in Fibrotic Interstitial Lung Disease.
21:1007-1014.
2024
-
Sex and Racial Differences in Lung Biopsies for Interstitial Lung Diseases in Canada.
21:516-519.
2024
-
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report.
21:1-11.
2024
-
National Prevalence of Social Isolation and Loneliness in Adults with Chronic Obstructive Pulmonary Disease.
20:1709-1717.
2023
-
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.
20:1726-1734.
2023
-
Reply: Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19..
20:1372.
2023
-
Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose–Response Meta-analysis.
20:596-604.
2023
-
A Network Meta-analysis of Dexamethasone for Preventing Postextubation Upper Airway Obstruction in Children.
20:118-130.
2023
-
Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis.
19:2077-2086.
2022
-
Extended Duration Treatment of Tobacco Dependence: A Systematic Review and Meta-Analysis.
19:1390-1403.
2022
-
Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease.
19:962-970.
2022
-
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease.
19:863-867.
2022
-
Cuff Leak Test and Airway Obstruction in Mechanically Ventilated Intensive Care Unit Patients: A Pilot Randomized Controlled Clinical Trial.
19:238-244.
2022
-
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung Disease.
19:20-27.
2022
-
Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2.
18:2007-2017.
2021
-
Treatment Initiation in Patients with Interstitial Lung Disease in Canada.
18:1661-1668.
2021
-
The Societies’ Responsibility for Wellness: Healing for the Healer.
18:1458-1460.
2021
-
Cardiorespiratory Monitoring Data during Sleep in Healthy Canadian Infants.
17:1238-1246.
2020
-
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease.
17:1077-1084.
2020
-
Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to De Novo Antisynthetase Syndrome.
17:901-904.
2020
-
Weight Loss Interventions as Treatment of Obesity Hypoventilation Syndrome. A Systematic Review.
17:492-502.
2020
-
The Role of Positive Airway Pressure Therapy in Adults with Obesity Hypoventilation Syndrome. A Systematic Review and Meta-Analysis.
17:344-360.
2020
-
Noninvasive Ventilation versus CPAP as Initial Treatment of Obesity Hypoventilation Syndrome.
16:1295-1303.
2019
-
The Final Frontier: Preschool Asthma Severity—The Silent Years No More.
16:550-552.
2019
-
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.
16:22-28.
2019
-
Between-Visit Variability in FEV1 as a Diagnostic Test for Asthma in Adults.
15:1039-1046.
2018
-
Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population.
15:827-836.
2018
-
International Practice Variation in Weaning Critically Ill Adults from Invasive Mechanical Ventilation.
15:494-502.
2018
-
Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.
15:271-280.
2018
-
Management of Acute Respiratory Distress Syndrome and Refractory Hypoxemia. A Multicenter Observational Study.
14:1818-1826.
2017
-
High-Frequency Oscillation for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
14:S289-S296.
2017
-
Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
14:S297-S303.
2017
-
Low Tidal Volume versus Non–Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
14:S271-S279.
2017
-
Lung Recruitment Maneuvers for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
14:S304-S311.
2017
-
Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.
14:S280-S288.
2017
-
Skeletal Muscle Ultrasound in Critical Care: A Tool in Need of Translation.
14:1495-1503.
2017
-
Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.
14:1373-1377.
2017
-
The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
14:1288-1297.
2017
-
Airway Management Strategies for Brain-injured Patients Meeting Standard Criteria to Consider Extubation. A Prospective Cohort Study.
14:85-93.
2017
-
Corrections to an ATS Workshop Report on Multiple-Breath Washout Testing for Patients with Cystic Fibrosis.
14:145-145.
2017
-
Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
13:2132-2142.
2016
-
What’s in a Name? Factors Associated with Documentation and Evaluation of Incidental Pulmonary Nodules.
13:1704-1711.
2016
-
High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
13:1640-1647.
2016
-
An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders.
13:S12-S21.
2016
-
Identifying Molecular Mechanisms of the Late-Phase Asthmatic Response by Integrating Cellular, Gene, and Metabolite Levels in Blood.
13:S98-S98.
2016
-
Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?.
12:S207-S211.
2015
-
One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation.
12:1490-1497.
2015
-
The Effects of Repeated Bronchoprovocation on FEV1 in Subjects with Asthma.
12:1589-1591.
2015
-
Comparison of the Provocative Concentration of Methacholine Causing a 20% Fall in FEV1 between the AeroEclipse II Breath-Actuated Nebulizer and the Wright Nebulizer in Adult Subjects with Asthma.
12:1039-1043.
2015
-
Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.
12:932-939.
2015
-
Reliability of a Noninvasive Measure of V./Q. Mismatch for Bronchopulmonary Dysplasia.
12:727-733.
2015
-
Mechanisms of Peptide Immunotherapy in Allergic Airways Disease.
11:S292-S296.
2014
-
Severe Asthma.
11:996-997.
2014
-
Does Integration of Various Ion Channel Measurements Improve Diagnostic Performance in Cystic Fibrosis?.
11:562-570.
2014
-
The Loss of Topography in the Microbial Communities of the Upper Respiratory Tract in the Elderly.
11:513-521.
2014
-
The Cystic Fibrosis Lung Microbiome.
11:S61-S65.
2014
-
What to Expect When You’re Expectorating: Cystic Fibrosis Exacerbations and Microbiota.
10:249-250.
2013
-
An Official American Thoracic Society Workshop Report: Optimal Lung Function Tests for Monitoring Cystic Fibrosis, Bronchopulmonary Dysplasia, and Recurrent Wheezing in Children Less Than 6 Years of Age.
10:S1-S11.
2013
-
Disseminating and Implementing Guidelines.
9:298-303.
2012
-
Guideline Group Composition and Group Processes.
9:229-233.
2012
-
Incorporating Considerations of Cost-Effectiveness, Affordability, and Resource Implications in Guideline Development.
9:251-255.
2012
-
Stakeholder Involvement: How to Do It Right.
9:269-273.
2012
-
Deciding what type of evidence and outcomes to include in guidelines: article 5 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
9:243-250.
2012
-
Guideline funding and conflicts of interest: article 4 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
9:234-242.
2012
-
Identifying Target Audiences: Who Are the Guidelines For? Article 1 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report.
9:219-224.
2012
-
Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
9:262-268.
2012
-
Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
9:282-292.
2012
-
Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
9:256-261.
2012
-
Pulmonary Microcirculation in Interstitial Lung Disease.
8:516-521.
2011
-
Obstructive Lung Disease from Conception to Old Age: Differences in the Treatment of Adults and Children with Asthma.
6:720-723.
2009
-
18F-Fluorodeoxyglucose Positron Emission Tomographic Imaging of Pulmonary Functions, Pathology, and Drug Delivery.
6:477-485.
2009
-
An Official ATS Conference Proceedings: Advances in Small-Animal Imaging Application to Lung Pathophysiology.
5:591-600.
2008
-
The Similarities and Differences of Epidemic Cycles of Chronic Obstructive Pulmonary Disease and Asthma Exacerbations.
4:591-596.
2007
-
Positron Emission Tomography and Computed Tomography versus Positron Emission Tomography Computed Tomography: Tools for Imaging the Lung.
4:328-333.
2007
-
Lung Development and Susceptibility to Chronic Obstructive Pulmonary Disease.
3:668-672.
2006
-
Smad3 Signaling Involved in Pulmonary Fibrosis and Emphysema.
3:696-702.
2006
-
Targeting Genes for Treatment in Idiopathic Pulmonary Fibrosis: Challenges and Opportunities, Promises and Pitfalls.
3:389-393.
2006
-
A New ATS Committee: Competing in the Marketplace of Ideas.
2:249-250.
2005
-
Executive Summary: Management of the Critically Ill Patient with Severe Acute Pancreatitis.
1:289-290.
2004
-
Imaging Drug Delivery and Drug Responses in the Lung.
1:329-337.
2004
-
Introduction.
1:71-72.
2004
-
Pharmacologic Interventions to Reduce the Risk of Asthma Exacerbations.
1:105-108.
2004
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)